PARACELSIAN INC /DE/
NT 10-K, 1997-12-30
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: BEAR STEARNS MORTGAGE SECURITIES INC, 424B5, 1997-12-30
Next: NAVISTAR FINANCIAL RETAIL RECEIVABLES CORPORATION, 8-K, 1997-12-30





                                   Form 12b-25

                     U.S. SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                  FORM 12b-25        Commission File No. 0-19844
                                                                         -------

                           NOTIFICATION OF LATE FILING

                                  (Check One):

[X] Form 10-K and 10-KSB [ ]Form 20-F  [ ] Form 11-K  
[ ] Form 10-Q and 10-QSB [ ] Form N-SAR

For Period Ended: September 30, 1997

[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR

For the Transition Period Ended: 

- --------------------------------------------------------------------------------

         Nothing in this form shall be  construed  to imply that the  Commission
has verified any information contained herein.

- --------------------------------------------------------------------------------

         If the  notification  relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:

 ................................................................................
 ................................................................................

- --------------------------------------------------------------------------------

PART I - REGISTRANT INFORMATION

- --------------------------------------------------------------------------------


Full name of Registrant                          PARACELSIAN, INC.
                                                 -------------------------------

Former name if applicable                               N/A
                                                 -------------------------------

Address of principal executive office              22 LANGMUIR LABORATORIES
(street and number)                                CORNELL TECHNOLOGY PARK
                                                 -------------------------------

City, State and Zip Code                           ITHICA, NEW YORK  14850
                                                 -------------------------------


                                      - 1 -
<PAGE>
- --------------------------------------------------------------------------------

PART II - RULES 12B-25(b) AND (c)

- --------------------------------------------------------------------------------

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed.

[X]      (a)  The reasons  described  in  reasonable  detail in Part III of this
form could not be eliminated without unreasonable effort or expense;

[X]      (b)  The subject  annual report on Form 10-K,  Form 20-F,  11-K or Form
N-SAR, or portion thereof will be filed on or before the fifteenth  calendar day
following the prescribed due date; or the subject quarterly report or transition
report on Form  10-Q,  or portion  thereof  will be filed on or before the fifth
calendar day following the prescribed due date; and

[ ]      (c)  The  accountant's  statement  or other  exhibit  required  by Rule
12b-25(c) has been attached if applicable.

- --------------------------------------------------------------------------------

PART III - NARRATIVE

- --------------------------------------------------------------------------------

         Due to  recent  changes  in senior  management  and  other  staff,  the
Registrant  was unable to dedicate  sufficient  time to allow its  personnel  to
prepare its annual  report on Form 10-K for the  Registrant's  fiscal year ended
September  30, 1997 on a timely  basis.  On  September  17,  1997,  Keith Rhodes
resigned from his position as Chairman of the Board,  President and acting Chief
Financial  Officer.   On  that  same  date,  Thomas  Tachovsky  was  elected  by
Registrant's  Board of Directors as President and acting Chief Executive Officer
and Chief Financial  Officer.  The Registrant  expects to file its Form 10-K for
the fiscal year ended  September  30, 1997 by January 13, 1998, 15 calendar days
after December 29, 1997, the due date of such Report.

- --------------------------------------------------------------------------------

PART IV - OTHER INFORMATION

- --------------------------------------------------------------------------------

          (1)  Name and telephone  number of person to contact in regard to this
notification


        Thomas G. Tachovsky                         607-257-4224
        -----------------                        ------------------
               (Name)                            (Telephone Number)
 
 
         (2)  Have all other  periodic  reports  required  under  section 13 or
15(d) of the  Securities  Exchange  Act of 1934 or section 30 of the  Investment
Company Act of 1940 during the  preceding 12 months or for such  shorter  period
that the  registrant  was  required to file such  report(s)  been filed?  If the
answer is no, identify report(s).

                                                                [X] Yes   [ ] No

         (3)   Is it  anticipated  that any  significant  change in  results  of
operations  from the  corresponding  period  for the last  fiscal  year  will be
reflected by the  earnings  statements  to be included in the subject  report or
portion thereof?

                                                                [X] Yes   [ ] No


                                      - 2 -
<PAGE>

         If  so:  Attach  an  explanation  of  the  anticipated   change,   both
narratively and  quantitatively,  and, if  appropriate,  state the reasons why a
reasonable estimate of the results cannot be made.

                                Paracelsian, Inc.
                         ------------------------------
 
has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.


Date   December 29, 1997                    By /s/ Thomas G. Tachovsky
                                             --------------------------------


          ------------------------------------------------------------

                                    ATTENTION

         Intentional  misstatements  or  omissions  of fact  constitute  Federal
Criminal Violations (See 18 U.S.C. 1001).


          ------------------------------------------------------------


PART IV (3)


         The  significant   changes  in  the  results  of  operations  from  the
corresponding  period for the last fiscal year are the  write-off of  intangible
assets,  including the  Traditional  Chinese  Medicines  library,  the Licensing
Agreement  with the Chinese  Institute  of  Traditional  Medicine and patent and
trademarks.  This  reflects a right off of  $1,400,000  of the net assets of the
Company.


                                      - 3 -



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission